<DOC>
	<DOCNO>NCT00881244</DOCNO>
	<brief_summary>A Phase I open label study AS1411 advance solid tumour . Objectives include determine MTD DLT AS1411 , determine PK profile AS1411 obtain preliminary evidence clinical biological response AS1411 therapy .</brief_summary>
	<brief_title>Study AS1411 Advanced Solid Tumours</brief_title>
	<detailed_description />
	<criteria>Patients advance solid tumour refractory conventional/standard treatment Age &gt; / 18 year ECOG performance status &lt; / 2 ( Karnofsky &gt; /60 % Life expectancy &gt; / 8 week Adequate organ marrow function Radiotherapy chemotherapy 4 week study entry ( 6 week nitrosourea mitomycin C Lack recovery adverse event ( AEs ) cause agent administer study entry ; current use investigational agent ( ) Uncontrolled brain metastasis include need corticosteroid therapy Pregnancy Uncontrolled intercurrent illness Psychiatric illness/social situation could limit compliance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>